Total Payments
$284,278
2024 Payments
$14,529
Companies
30
Transactions
539
Medicare Patients
1,120
Medicare Billing
$215,124
Payment Breakdown by Category
Other$193,849 (68.2%)
Consulting$51,512 (18.1%)
Travel$25,642 (9.0%)
Food & Beverage$11,496 (4.0%)
Research$1,608 (0.6%)
Education$171.48 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $157,559 | 75 | 55.4% |
| Consulting Fee | $51,512 | 20 | 18.1% |
| Honoraria | $36,290 | 20 | 12.8% |
| Travel and Lodging | $25,642 | 132 | 9.0% |
| Food and Beverage | $11,496 | 271 | 4.0% |
| Unspecified | $1,608 | 16 | 0.6% |
| Education | $171.48 | 5 | 0.1% |
Payments by Type
General
$282,670
523 transactions
Research
$1,608
14 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $150,711 | 239 | $0 (2024) |
| La Jolla Pharmaceutical Company | $83,116 | 103 | $0 (2022) |
| Astute Medical, Inc. | $15,766 | 34 | $0 (2018) |
| Travere Therapeutics, Inc. | $10,120 | 12 | $0 (2022) |
| GlaxoSmithKline, LLC. | $5,750 | 4 | $0 (2023) |
| Retrophin, Inc. | $4,953 | 17 | $0 (2019) |
| CALLIDITAS THERAPEUTICS US INC. | $3,190 | 4 | $0 (2024) |
| Amarin Pharma Inc. | $1,950 | 2 | $0 (2024) |
| Relypsa, Inc. | $1,913 | 17 | $0 (2020) |
| EchoNous, Inc. | $1,804 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14,529 | 15 | AstraZeneca Pharmaceuticals LP ($10,963) |
| 2023 | $22,846 | 30 | AstraZeneca Pharmaceuticals LP ($22,477) |
| 2022 | $29,685 | 49 | AstraZeneca Pharmaceuticals LP ($16,511) |
| 2021 | $24,540 | 62 | AstraZeneca Pharmaceuticals LP ($18,186) |
| 2020 | $21,191 | 41 | AstraZeneca Pharmaceuticals LP ($13,695) |
| 2019 | $108,589 | 195 | AstraZeneca Pharmaceuticals LP ($68,265) |
| 2018 | $47,099 | 84 | La Jolla Pharmaceutical Company ($42,184) |
| 2017 | $15,801 | 63 | Astute Medical, Inc. ($12,994) |
All Payment Transactions
539 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Nephrology | ||||||
| 10/01/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Travel and Lodging | Cash or cash equivalent | $50.99 | General |
| Category: Nephrology | ||||||
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $130.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,950.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $106.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $46.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/08/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: Nephrology | ||||||
| 04/04/2024 | Amarin Pharma Inc. | Vascepa (Drug) | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| Category: cardiovascular | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,450.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $140.70 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.37 | General |
| 01/17/2024 | CALLIDITAS THERAPEUTICS US INC. | TARPEYO (Drug) | Food and Beverage | In-kind items and services | $126.43 | General |
| Category: Nephrology | ||||||
| 11/03/2023 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $40.08 | General |
| Category: Treatment of certain chronic autoimmune disorders, including acute exacerbations of MS and RA | ||||||
| 10/12/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $220.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $32.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/30/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/14/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $15.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/07/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/03/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $142.79 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,700.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| 021IGAN17001 | Retrophin, Inc. | $986.75 | 8 |
| BAY 94 8862 ph 3 conventional in diab nephropathy | Bayer HealthCare Pharmaceuticals Inc. | $621.59 | 6 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 225 | 402 | $126,002 | $35,463 |
| 2022 | 7 | 296 | 682 | $231,958 | $54,283 |
| 2021 | 5 | 231 | 680 | $175,448 | $49,089 |
| 2020 | 5 | 368 | 1,012 | $265,304 | $76,289 |
Total Patients
1,120
Total Services
2,776
Medicare Billing
$215,124
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 64 | 155 | $54,250 | $13,887 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 57 | 116 | $30,044 | $10,405 | 34.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 51 | 78 | $17,940 | $4,622 | 25.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 29 | 29 | $15,080 | $3,807 | 25.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $8,688 | $2,741 | 31.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 88 | 321 | $112,350 | $24,676 | 22.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 55 | 148 | $34,040 | $7,889 | 23.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 52 | 52 | $27,040 | $7,450 | 27.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 33 | 61 | $15,175 | $5,849 | 38.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $10,496 | $3,293 | 31.4% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 24 | 56 | $26,712 | $3,065 | 11.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $6,145 | $2,062 | 33.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 61 | 256 | $66,492 | $20,398 | 30.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 84 | 270 | $45,915 | $14,957 | 32.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 35 | 35 | $13,720 | $5,508 | 40.1% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2021 | 28 | 78 | $41,966 | $4,535 | 10.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 41 | $7,355 | $3,692 | 50.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 135 | 453 | $74,745 | $26,570 | 35.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 83 | 266 | $64,904 | $22,419 | 34.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 75 | 84 | $31,730 | $13,732 | 43.3% |
| 90935 | Hemodialysis procedure with one physician evaluation | Facility | 2020 | 51 | 155 | $84,475 | $9,291 | 11.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 54 | $9,450 | $4,277 | 45.3% |
About Dr. Harold Szerlip, MD
Dr. Harold Szerlip, MD is a Internal Medicine healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1942394432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harold Szerlip, MD has received a total of $284,278 in payments from pharmaceutical and medical device companies, with $14,529 received in 2024. These payments were reported across 539 transactions from 30 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($157,559).
As a Medicare-enrolled provider, Szerlip has provided services to 1,120 Medicare beneficiaries, totaling 2,776 services with total Medicare billing of $215,124. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology, Nephrology
- Location Charleston, SC
- Active Since 10/02/2006
- Last Updated 03/02/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1942394432
Products in Payments
- LOKELMA (Drug) $102,476
- GIAPREZA (Drug) $82,945
- FARXIGA (Drug) $47,421
- NephroCheck Test (Device) $12,894
- BENLYSTA (Biological) $5,750
- TARPEYO (Drug) $3,190
- Nephrocheck (Device) $2,772
- Veltassa (Drug) $2,036
- Vascepa (Drug) $1,950
- Kosmos (Device) $1,804
- JARDIANCE (Drug) $1,562
- Non-Covered $645.61
- INVOKANA (Drug) $375.00
- BRILINTA (Drug) $370.86
- Rayaldee (Drug) $181.06
- ACTHAR (Biological) $171.22
- SYSTEM ONE (Device) $157.69
- Envarsus (Drug) $151.90
- JYNARQUE (Drug) $146.31
- Rituxan (Biological) $142.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charleston
William Chapman, Do, DO
Internal Medicine — Payments: $1.3M
Internal Medicine $1.3M
Dr. Ryan Tedford, M.d, M.D
Internal Medicine — Payments: $432,170
Internal Medicine $432,170
Dr. Nathan Shores, M.d, M.D
Internal Medicine — Payments: $262,570
Internal Medicine $262,570
Hamza Hashmi, M.d, M.D
Internal Medicine — Payments: $234,146
Internal Medicine $234,146
Dr. Anne Kroman, D.o., Phd, D.O., PHD
Internal Medicine — Payments: $202,518
Internal Medicine $202,518
Alejandro Suarez, M.d, M.D
Internal Medicine — Payments: $200,305
Internal Medicine $200,305